|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9284 USD | -3.26% |
|
-11.58% | +10.72% |
| May. 09 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
| May. 09 | X4 Pharmaceuticals Receives $125 Million Additional Capital; Shares Rise | MT |
X4 Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 51.77 million compared to USD 24.02 million a year ago. Basic loss per share from continuing operations was USD 0.26 compared to USD 0.16 a year ago.
Diluted loss per share from continuing operations was USD 0.26 compared to USD 0.16 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +10.72% | 156M | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -1.05% | 21.96B | |
| -14.15% | 21.87B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
X4 PHARMACEUTICALS, INC. 
